First Clinical Trial Led by UT Southwestern Researchers (IMAGE)
Caption
Dr. Abhimanyu Garg examines Dwanna Swan, a generalized lipodystrophy patient whom he has been treating for 14 years. The drug that Mrs. Swan has been taking as part of a clinical trial, metreleptin, was approved by the FDA today for treatment of this rare disease.
Credit
UT Southwestern Medical Center
Usage Restrictions
None
License
Licensed content